Gilead Sciences Inc Arcus Biosciences, Inc. (RCUS) insider trading activity
Gilead Sciences Inc is > 10% Shareholder of Arcus Biosciences, Inc.. Currently has a direct ownership of 31.4 Million shares of RCUS, which is worth approximately $342 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 1,363,636 shares (Common Stock) at a price of $11.0 per share, resulting in proceeds of $14,999,996. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
31.4M
4.54%
3M change
4.54%
12M change
Total Value Held
$342 Million
GILEAD SCIENCES INC Transaction History
Also insider at
GSI
Gilead Sciences Inc
> 10% Shareholder
Foster City, CA